- Home
- DGX vs LII Comparison
DGX vs LII Comparison
Compare DGX & LII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DGX
- LII
- Stock Information
- Founded
- DGX 1967
- LII 1895
- Country
- DGX United States
- LII United States
- Employees
- DGX N/A
- LII N/A
- Industry
- DGX Medical Specialities
- LII Industrial Machinery/Components
- Sector
- DGX Health Care
- LII Industrials
- Exchange
- DGX Nasdaq
- LII Nasdaq
- Market Cap
- DGX 19.8B
- LII 21.4B
- IPO Year
- DGX 1996
- LII 1999
- Fundamental
- Price
- DGX $170.83
- LII $605.63
- Analyst Decision
- DGX Buy
- LII Hold
- Analyst Count
- DGX 15
- LII 12
- Target Price
- DGX $185.40
- LII $649.91
- AVG Volume (30 Days)
- DGX 1.4M
- LII 401.5K
- Earning Date
- DGX 07-22-2025
- LII 07-23-2025
- Dividend Yield
- DGX 1.87%
- LII 0.86%
- EPS Growth
- DGX 12.66
- LII 29.66
- EPS
- DGX 8.35
- LII 23.38
- Revenue
- DGX $10,522,000,000.00
- LII $5,416,600,000.00
- Revenue This Year
- DGX $10.88
- LII $3.46
- Revenue Next Year
- DGX $3.68
- LII $5.61
- P/E Ratio
- DGX $20.47
- LII $25.91
- Revenue Growth
- DGX 12.58
- LII 7.91
- 52 Week Low
- DGX $142.86
- LII $500.10
- 52 Week High
- DGX $182.38
- LII $689.44
- Technical
- Relative Strength Index (RSI)
- DGX 49.27
- LII 47.85
- Support Level
- DGX $166.75
- LII $598.25
- Resistance Level
- DGX $180.89
- LII $689.44
- Average True Range (ATR)
- DGX 4.65
- LII 17.47
- MACD
- DGX 0.14
- LII -3.89
- Stochastic Oscillator
- DGX 38.05
- LII 17.44
About DGX Quest Diagnostics Incorporated
Quest Diagnostics Inc is a leading independent provider of diagnostic testing, information, and services in the us. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
About LII Lennox International Inc.
Lennox International manufactures and distributes heating, ventilating, air conditioning, and refrigeration products to replacement (75% of sales) and new construction (25% of sales) markets. In fiscal 2024, residential HVAC was 67% of sales and commercial HVAC and Heatcraft refrigeration was 33% of sales. The company goes to market with multiple brands, but Lennox is the company's flagship HVAC brand. The Texas-based company is focused on North America after the sale of its European HVAC and refrigeration businesses in late 2023.